Exchange Traded Concepts, LLC Nektar Therapeutics Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 13, 2022
SELL
$10.83 - $18.41 $10,115 - $17,194
-934 Closed
0 $0
Q3 2021

Oct 18, 2021
BUY
$13.07 - $18.84 $12,207 - $17,596
934 New
934 $17,000
Q1 2021

Apr 20, 2021
SELL
$16.56 - $25.46 $237,884 - $365,732
-14,365 Closed
0 $0
Q4 2020

Jan 19, 2021
BUY
$15.77 - $19.03 $10,313 - $12,445
654 Added 4.77%
14,365 $244,000
Q3 2020

Oct 30, 2020
BUY
$16.59 - $24.79 $227,465 - $339,895
13,711 New
13,711 $227,000

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email